Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

2.3K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.3K
Hazard Ratio01:12

Hazard Ratio

670
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
670
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

472
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
472
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

677
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
677
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

903
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
903
Contingency Table01:29

Contingency Table

4.6K
A contingency table provides a way of portraying data that can facilitate calculating probabilities. It is a method of displaying a frequency distribution as a table with rows and columns to show how two variables may be dependent (contingent) upon each other; The table helps determine conditional probabilities quite quickly and can help systematically organize, analyze and quantify data. The table displays sample values concerning two variables that may be dependent or contingent on one...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in acute myeloid leukemia in first complete remission: CIBMTR analysis.

Haematologica·2026
Same author

Controlling FDR in selecting group-level simultaneous signals from multiple data sources with application to the National COVID Collaborative Cohort data.

Journal of applied statistics·2026
Same author

Variable Selection with FDR Control for Noisy Data - An Application to Screening Metabolites that Are Associated with Breast Cancer and Colorectal Cancer.

Journal of data science : JDS·2026
Same author

Sterol pathway disruption in pregnancy: a link to autism.

Molecular psychiatry·2026
Same author

Structure-Activity Mapping of Intraperitoneal mRNA-LNPs: Decoupling Tumor and Liver Biodistribution in Pancreatic Cancer.

bioRxiv : the preprint server for biology·2026
Same author

Outcomes of myeloablative allogeneic hematopoietic cell transplantation with omidubicel vs alternative donor sources.

Blood neoplasia·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 9, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Instrumental variable with competing risk model.

Cheng Zheng1, Ran Dai2, Parameswaran N Hari3

  • 1Joseph. J. Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, U.S.A.

Statistics in Medicine
|January 9, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces an instrumental variable method to accurately estimate treatment efficacy for time-to-event outcomes, even with unmeasured confounding factors in competing risk scenarios.

Keywords:
additive hazard modelcompeting riskinstrumental variablesurvival analysis

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.4K

Related Experiment Videos

Last Updated: Mar 9, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.4K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Clinical Research Methodology

Background:

  • Estimating treatment efficacy in time-to-event studies with competing risks is challenging.
  • Randomized treatments may still suffer from unmeasured confounding between compliance and outcomes.
  • Instrumental variable (IV) methods are crucial for addressing unmeasured confounders.

Purpose of the Study:

  • To develop a novel instrumental variable estimator for causal inference.
  • To provide consistent estimation of treatment efficacy in competing risk settings with unmeasured confounding.
  • To evaluate the performance of the proposed method in simulations and real-world data.

Main Methods:

  • Development of a semiparametric additive hazard model for subdistribution hazards.
  • Application of instrumental variable techniques within the competing risks framework.
  • Derivation of asymptotic properties for the proposed instrumental variable estimator.

Main Results:

  • The proposed instrumental variable estimator provides consistent estimation of treatment efficacy.
  • Simulation studies demonstrate good performance of the estimator in finite sample sizes.
  • Analysis of transplant data revealed significant bias (approx. 50% attenuation) due to unmeasured confounding.

Conclusions:

  • The instrumental variable approach effectively corrects for unmeasured confounding in competing risk analyses.
  • Accurate estimation of treatment efficacy is achievable even with complex confounding structures.
  • The method has practical implications for interpreting treatment effects in observational and clinical studies.